# Sun Pharmaceutical Industries, Inc. trials: 80 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 80 trials with Sun Pharmaceutical Industries, Inc. as lead sponsor, 3 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Sun Pharmaceutical Industries, Inc.: 80 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/sun-pharmaceutical-industries-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 80
- Recruiting or not yet: 3
- Read on: November 19, 2026

## Trials

The 25 newest of 80, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 31, 2026 | NCT07795567 | A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe... | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Rosacea | 865 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795567) |
| April 22, 2026 | NCT07546214 | A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis. | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Plaque Psoriasis | 575 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07546214) |
| March 13, 2026 | NCT07469228 | A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Acne Vulgaris | 1,043 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07469228) |
| August 28, 2025 | NCT07144852 | Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities | Sun Pharmaceutical Industries, Inc. | Phase 3 | Recruiting | Actinic Keratosis | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07144852) |
| August 27, 2025 | NCT07144345 | Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp | Sun Pharmaceutical Industries, Inc. | Phase 3 | Recruiting | Actinic Keratosis | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07144345) |
| August 21, 2025 | NCT07133308 | Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata | Sun Pharmaceutical Industries, Inc. | Phase 3 | Recruiting | Alopecia Areata | 355 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07133308) |
| December 13, 2024 | NCT06733402 | A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the... | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Acne Vulgaris | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06733402) |
| November 5, 2024 | NCT06673654 | A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of... | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Atopic Dermatitis | 476 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06673654) |
| November 5, 2024 | NCT06673641 | A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.)... | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Acne Vulgaris | 382 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06673641) |
| March 12, 2024 | NCT06305637 | A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor. | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Tinea Versicolor | 430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06305637) |
| October 2, 2023 | NCT06063473 | A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Acne Vulgaris | 762 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06063473) |
| March 16, 2022 | NCT05282771 | A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and... | Sun Pharmaceutical Industries, Inc. | Early phase 1 | Completed | Plaque Psoriasis | 402 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05282771) |
| December 8, 2021 | NCT05148689 | A Study Comparing Oxymetazoline 1% Cream to RHOFADE | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Bioequivalence | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05148689) |
| September 13, 2021 | NCT05041803 | European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata | Sun Pharmaceutical Industries, Inc. | Phase 3 | Completed | Alopecia Areata | 407 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05041803) |
| May 12, 2021 | NCT04883736 | A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris | Sun Pharmaceutical Industries, Inc. | Early phase 1 | Completed | Acne Vulgaris | 973 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04883736) |
| May 12, 2021 | NCT04883593 | A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis. | Sun Pharmaceutical Industries, Inc. | Early phase 1 | Completed | Tinea Pedis | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04883593) |
| March 15, 2021 | NCT04797793 | A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris | Sun Pharmaceutical Industries, Inc. | Early phase 1 | Completed | Acne Vulgaris | 978 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04797793) |
| January 26, 2021 | NCT04724473 | A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris | Sun Pharmaceutical Industries, Inc. | Early phase 1 | Completed | Acne Vulgaris | 1,030 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04724473) |
| April 24, 2020 | NCT04358770 | Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Bioequivalence Study | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04358770) |
| March 25, 2020 | NCT04321070 | Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Acne Vulgaris | 550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04321070) |
| October 22, 2019 | NCT04134273 | Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Acne Vulgaris | 1,260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04134273) |
| April 2, 2019 | NCT03898479 | Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata | Sun Pharmaceutical Industries, Inc. | Phase 2/3 | Active not recruiting | Alopecia Areata | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03898479) |
| March 19, 2019 | NCT03880357 | To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Scalp Psoriasis | 485 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03880357) |
| September 28, 2018 | NCT03689010 | To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Rosacea | 1,116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03689010) |
| August 24, 2018 | NCT03645499 | An Open-Label Study to Assess Safety | Sun Pharmaceutical Industries, Inc. | Phase 1 | Completed | Plaque Psoriasis | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03645499) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 7 |
| Phase 1 | 41 |
| Phase 2 | 16 |
| Phase 2/3 | 2 |
| Phase 3 | 13 |
| Phase 4 | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 71 |
| Terminated | 5 |
| Recruiting | 3 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Acne Vulgaris | 22 |
| Tinea Pedis | 8 |
| Lice Infestations | 7 |
| Dermatitis, Atopic | 5 |
| Keratosis, Actinic | 5 |
| Psoriasis | 5 |
| Rosacea | 4 |
| Alopecia Areata | 3 |
| Movement Disorders | 3 |
| Skin Diseases | 2 |
| Precancerous Conditions | 2 |
| Essential Tremor | 2 |
| Onychomycosis | 2 |
| Myoclonus | 1 |
| Myoclonic dystonia | 1 |
| Dyskinesias | 1 |
| Tinea Versicolor | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [AV equipment rental companies in the United States](https://specstream.ai/data/businesses/av-equipment-rental-companies/united-states)
- [Hotels in the United States](https://specstream.ai/data/businesses/hotels/united-states)
- [Temp agencies in the United States](https://specstream.ai/data/businesses/temp-agencies/united-states)
- [Educational research institutes in the United States](https://specstream.ai/data/businesses/educational-research-institutes/united-states)
- [Pool and hot tub services in the United States](https://specstream.ai/data/businesses/pool-and-hot-tub-services/united-states)
